Fatal tracheal perforation following Dabrafenib-Trametinib therapy in BRAF V600E-mutant mixed anaplastic thyroid cancer.

Matrone A, Scordo M, Minaldi E, Torregrossa L, Materazzi G, Elisei R

Open source

DOI
10.1210/jcemcr/luag027
Published
2026 Mar
Container
JCEM case reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1210/jcemcr/luag027,
  title = {Fatal tracheal perforation following Dabrafenib-Trametinib therapy in BRAF V600E-mutant mixed anaplastic thyroid cancer.},
  author = {Matrone A and Scordo M and Minaldi E and Torregrossa L and Materazzi G and Elisei R},
  year = {2026},
  journal = {JCEM case reports},
  doi = {10.1210/jcemcr/luag027},
  url = {https://doi.org/10.1210/jcemcr/luag027}
}

RIS

TY  - JOUR
TI  - Fatal tracheal perforation following Dabrafenib-Trametinib therapy in BRAF V600E-mutant mixed anaplastic thyroid cancer.
AU  - Matrone A
AU  - Scordo M
AU  - Minaldi E
AU  - Torregrossa L
AU  - Materazzi G
AU  - Elisei R
PY  - 2026
JO  - JCEM case reports
DO  - 10.1210/jcemcr/luag027
UR  - https://doi.org/10.1210/jcemcr/luag027
ER  - 

APA

A, M., M, S., E, M., L, T., G, M., & R, E. (2026). Fatal tracheal perforation following Dabrafenib-Trametinib therapy in BRAF V600E-mutant mixed anaplastic thyroid cancer.. JCEM case reports. https://doi.org/10.1210/jcemcr/luag027

Source records